A phase I-II study of isolated hepatic perfusion using melphalan with or without tumor necrosis factor for patients with ocular melanoma metastatic to liver

H. Richard Alexander, Steven K. Libutti, David L. Bartlett, Markus Puhlmann, Douglas L. Fraker, Lisa C. Bachenheimer

Research output: Contribution to journal › Article › peer-review

138 Scopus citations

Fingerprint

Dive into the research topics of 'A phase I-II study of isolated hepatic perfusion using melphalan with or without tumor necrosis factor for patients with ocular melanoma metastatic to liver'. Together they form a unique fingerprint.

Medicine & Life Sciences